Chronic intravenous injections of antigen induce and maintain tolerance in T cell receptor-transgenic mice

European Journal of Immunology

Volumn 29, Issue 1, 1999, Pages 345-354

  Bercovici, Nadège ^a,b   Delon, Jérome ^a   Cambouris, Christophe ^a,b   Escriou, Nicolas ^c   Debré, Patrice ^a   Liblau, Roland S ^a,b  

^a Laboratoire d'Immunologie Cellulaire et Tissulaire CNRS URA 625   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

T cell; T cell receptor transgenic; Tolerance

Indexed keywords

CD4 ANTIGEN; INFLUENZA VIRUS HEMAGGLUTININ; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HALF LIFE TIME; IMMUNOLOGICAL TOLERANCE; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMECTOMY; THYMOCYTE; TRANSGENE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CALCIUM; CD4-POSITIVE T-LYMPHOCYTES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNE TOLERANCE; INJECTIONS, INTRAVENOUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; SELF TOLERANCE;

EID: 0032895886     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199901)29:01<345::AID-IMMU345>3.0.CO;2-K     Document Type: Article

References (38)

1. Mitchison, N. A., Induction of immunological paralysis in two zones of dosage. Proc. R. Soc. 1964. 161: 275-292.
2. Dresser, D. W., Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology 1962. 5: 378-388.
3. Chiller, J. M., Habicht, G. S. and Weigle, W. O., Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science 1971. 171: 813-815.
4. Kyburz, D., Aichele, P., Speiser, D. E., Hengartner, H., Zinkernagel, R. M. and Pircher, H., T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 1993. 23: 1956-1962.
5. Kearney, E. R., Pape, K. A., Loh, D. Y. and Jenkins, M. K., Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994. 1: 327-339.
6. Aichele, P., Kyburz, D., Ohashi, P. S., Odermatt, B., Zinkernagel, R. M., Hengartner, H. and Pircher, H., Peptide-induced T cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 1994. 91: 444-448.
7. + T cells. J. Exp. Med. 1997. 185: 405-414.
8. Webb, S., Morris, C. and Sprent, J., Extrathymic tolerance of mature T cells : clonal elimination as a consequence of immunity. Cell 1990. 63: 1249-1256.
9. Jones, L. A., Chin, L. T., Longo, D. L. and Kruisbeek, A. M., Peripheral clonal elimination of functional T cells. Science 1990. 250: 1726-1729.
10. Mamalaki, C., Tanaka, Y., Corbella, P., Chandler, P., Simpson, E. and Kioussis, D., T cell deletion follows chronic antigen specific T cell activation in vivo. Int. Immunol. 1993. 5: 1285-1292.
11. Moskophidis, D., Lechner, F., Pircher, H. and Zinkernagel, R. M., Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993. 362: 758-761.
12. Critchfield, J. M., Racke, M. K., Zuniga-Pflucker, J. C., Cannella, B., Raine, C. S., Goverman, J. and Lenardo, M. J., T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994. 263: 1139-1143.
13. Zal, T., Volkmann, A. and Stockinger, B., Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 1994. 180: 2089-2099.
14. Liblau, R. S., Tisch, R., Shokat, K., Yang, X. D., Dumont, N., Goodnow, C. C. and McDevitt, H. O., Intravenous injection of high-dose soluble antigen induces thymic and peripheral T cell apoptosis. Proc. Natl. Acad. Sci. USA 1996. 93: 3031-3036.
15. Sytwu, H. K., Liblau, R. S. and McDevitt, H. O., The role of Fas/APO (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996. 5: 17-30.
16. Schönrich, G., Momburg, F., Hämmerling, G. J. and Arnold, B., Anergy induced by thymic medullary epithelium. Eur. J. Immunol. 1992. 22: 1687-1691.
17. Falb, D., Briner, T. J., Sunshine, G. H., Bourque, C. R., Luqman, M., Gefter, M. L. and Kamradt, T., Peripheral tolerance in T cell receptor-transgenic mice : evidence for T cell anergy. Eur. J. Immunol. 1996. 26: 130-135.
18. Perez, V. L., Van Parijs, L., Biluckians, A., Zheng, X. X., Stom, T. B. and Abbas, A. K., Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997. 6: 411-417.
19. Rocha, B. and von Boehmer, H., Peripheral selection of the T cell repertoire. Science 1991. 251: 1225-1228.
20. De Wit, D., Van Mechelem, M., Ryelandt, M., Figueiredo, A. C., Abramowicz, D., Goldman, M., Bazin, H., Urbain, J. and Leo, O., The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J. Exp. Med. 1992. 175: 9-14.
21. Burstein, H. J. and Abbas, A. K., In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J. Exp. Med. 1993. 177: 457-463.
22. Forsthuber, T., Yip, H. C. and Lehmann, P. V., Induction of Th1 and Th2 immunity in neonatal mice. Science 1996. 271: 1728-1730.
23. Guery, J. C., Galbiati, F., Smiroldo, S. and Adorini, L., Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and β3-microglobulin-deficient Balb/c mice. J. Exp. Med. 1996. 183: 485-497.
24. Racke, M. K., Critchfield, J. M., Quickley, L., Cannella, B., Raine, C. S., McFarland, H. F. and Lenardo, M. J., Intravenous antigen administration as a therapy for autoimmune demyelinating disease. Ann. Neurol. 1996. 39: 46-56.
25. Ramsdell, F. and Fowlkes, B. J., Maintenance of in vivo tolerance by persistence of antigen. Science 1992. 257: 1130-1134.
26. Rocha, B., Tanchot, C. and von Boehmer, H., Clonal anergy blocks in vivo growth of matue T cells and can be reversed in the absence of antigen. J. Exp. Med. 1993. 177: 1517-1521.
27. + T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 1998. 160: 4719-4729.
28. Ben Nun, A., Wekerle, H. and Cohen, I. R., The rapid isolation of clonable antigen-specific T lymphocyte line capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 1981. 11: 195-199.
29. Katz, J. D., Benoist, C. and Mathis, D., T helper cell subsets in insulin-dependent diabetes. Science 1995. 268: 1185-1188.
30. Scott, B., Liblau, R., Degerman, S. Marconi, A. L., Caton, A. J., McDevitt, H. O. and Lo, D., A role for non-MHC genetic polymorphism in susceptibillity to spontaneous autoimmunity. Immunity 1994. 1: 72-83.
31. Müller, K. P., Schumacher, J. and Kyewski, B. A., Half-life of antigen/major histocompatibility complex class II complexes in vivo : intra- and inter-organ variations. Eur. J. Immunol. 1993. 23: 3203-3207.
32. Martin, S. and Bevan, M. J., Antigen-specific and non-specific deletion of immature cortical thymocytes caused by antigen injection. Eur J. Immunol. 1997. 27: 2726-2736.
33. Tighe, H., Corr, M., Roman, M. and Raz, E., Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today 1998. 19: 89-97.
34. + T cell deletion. Immunity 1995. 3: 321-333.
35. Jameson, S. C. and Bevan, M. J., T cell receptor antagonists and partial agonists. Immunity 1995. 2: 1-11.
36. Sloan-Lancaster, J., Steinberg, T. H. and Allen, P. M., Selective activation of the calcium signaling pathway by altered peptide ligands. J. Exp. Med. 1996. 184: 1525-1530.
37. Liblau, R. S., Tisch, R., Bercovici, N. and McDevitt, H. O., Systemic antigen in the treatment of T-cell-mediated autoimmune diseases. Immunol. Today 1997. 18: 599-604.
38. Donnadieu, E., Bismuth, G. and Trautmann, A., Antigen recognition by helper T cells elicits a sequence of distinct changes of their shape and intracellular calcium. Curr. Biology 1994. 4: 584-595.